WWhyIHold
$45.62-1.96%as of Nov 6, 2026
Prev close
$46.53
Day range
$45.30 – $46.09

EXC’s latest move was a small +0.5% gain while the S&P 500 fell -1.8% and the Nasdaq 100 fell -3.5%, and the backdrop was a utility-specific positive from Illinois ICC approval of the GRIT transmission project. The setup is broadly supportive, but the stock already trades at 17.1 times earnings and 2.11 on PEG, so the picture is solid rather than especially compelling.

EXC

EXELON CORP

As of Nov 1, 2026

68/100

Worth keeping an eye onHealth Score

Move driver

EXC finished up +0.5% even as the S&P 500 fell -1.8% and the Nasdaq 100 fell -3.5%, so the session was clearly not a broad-market rally. The more likely primary driver was stock-specific utility news: Illinois regulators approved ComEd’s GRIT transmission project on October 22, 2026, which supports rate-base growth and reliability investment for Exelon’s regulated utility footprint.

Volatility check

This looks like ordinary, news-backed volatility rather than a deterioration signal. Revenue is growing +6.6% YoY (TTM) and the latest quarter was +9.9% YoY, while EPS is +3.7% YoY (TTM); margins are also respectable at gross +40.4%, operating +20.8%, and net +11.0%. Valuation is not cheap at PE 17.1 and forward PE 15.3, with a PEG of 2.11, so some of the company’s growth is already priced in, which can limit upside but also makes the stock sensitive to incremental regulatory or earnings news. The beta of 0.24 is consistent with a comparatively muted price profile.

Earnings preview

The facts do not provide a confirmed next earnings date, so the next report date isn’t available this period. The available pre-earnings context is constructive: the company is described as expected to beat earnings estimates, and the underlying numbers show revenue growth of +6.6% YoY (TTM) and +9.9% YoY in the latest quarter, with EPS up +3.7% YoY (TTM) and margins at gross +40.4%, operating +20.8%, and net +11.0%. The market will be focused on whether regulated-rate-base execution, including the GRIT approval, translates into sustained earnings growth, whether the recent revenue trend holds, and whether management keeps the utility margin profile intact.

This report is for informational and educational purposes only. It does not constitute financial, investment, tax, or legal advice. The platform does not recommend buying or selling any security.

Track EXC with WhyIHold

Get a plain-English explanation the next time EXELON CORP makes a big move — so you know whether it's benign or worth your attention.